Background: Pheochromocytomas (PCs) are neuroendocrine tumors arising from the chromaffin cells of the adrenal gland, and paragangliomas (PGLs) are their extra-adrenal counterparts arising from ganglia along the sympathetic/parasympathetic chain. Surgery is the cornerstone of treatment. A sporatic or inherited germline mutation is commonly associated.
Materials and methods: Among over 1000 patients registered into the Tumori Rari in EtàPediatrica-rare tumors in pediatric age project-from 2000 to 2019, 50 were affected by PC/PGL. All clinical and therapeutic data were evaluated.Results: Twenty-eight patients had PC and 22 had PGL. Age at diagnosis ranged between 5 and 17 years. Thirty-five patients had symptoms related to catecholamine hypersecretion; in 7 of 50 patients, diagnosis was incidental or done during assessment of a familial syndrome. In all cases, conventional imaging was effective to assess the presence of a tumor. In addition, 18 of 38 functional imaging studies were positive (61%). Forty-eight patients were eligible for surgery: a complete resection was more frequently achieved in PC than in PGL (26/28 vs 11/22). All relapses were treated with surgery alone, surgery plus medical treatment, or chemotherapy alone; one PC with metastasis at diagnosis received radiotherapy only. Forty-four patients were in the first, second, or third complete remission (10/50 recurred; 8/10 carried a germline mutation). Five of 50 patients were alive with disease. One patient died of disease.Abbreviations: 18 F-DOPA, fluorine-18-L-dihydroxyphenylalanine; 18 F-FDG, fluorine-18-fluorodeoxyglucose; 123 I-MIBG, 123 iodium-metaiodobenzylguanidine; 177 Lu-DOTATATE, lutetium-177-DOTA 0 -Tyr 3 -octreotate; CT, computed tomography; EFS, event-free survival; Max, MYC-associated factor X; MRI, magnetic resonance imaging; NF1, neurofibromin 1; OS, overall survival; PC, pheochromocytoma; PET/CT, positron emission tomography/computed tomography; PGL, paraganglioma; Ret, rearranged during transfection; SDHA, succinate dehydrogenase complex flavoprotein subunit A; SDHAF2, succinate dehydrogenase complex assembly factor 2; SDHB, succinate dehydrogenase complex iron sulfur subunit B; SDHC, succinate dehydrogenase complex subunit C; SDHD, succinate dehydrogenase complex subunit D; TMEM127, transmembrane protein 127; TREP, Tumori Rari in Età Pediatrica-rare tumors in pediatric age; VHL, von Hippel-Lindau.